Permeability of triamcinolone acetonide, released from mucoadhesive films, through a buccal mucosa-mimetic barrier: PermeapadTM
Muhannad Alhallak,Natalia Karpukhina,Mangala Patel
DOI: https://doi.org/10.1016/j.dental.2024.06.016
2024-06-22
Dental Materials Journal
Abstract:Highlights • Bilayer mucoadhesive buccal films to enhance TA permeability through PermeapadTM. • F1-highest TA retention in PermeapadTM for potentially treating oral mucosa disorders. • EC backing layer minimized the loss of TA into the donor compartment. • The biomimetic membrane, PermeapadTM was successfully used for TA permeation assay. • Franz cell was used to predict the amount of drug permeating across PermeapadTM. Objectives The permeability of triamcinolone acetonide (TA), from bilayer mucoadhesive buccal films, through a biomimetic membrane, PermeapadTM, was investigated employing Franz diffusion cell. The delivery systems composition and ethyl cellulose (EC) backing layer, on drug permeability, were assessed. Methods Three TA-loaded films were tested; hydroxypropyl methylcellulose (HPMC K4M; bilayer [F1] and monolayer), HPMC K4M/Polyvinylpyrrolidone (PVP): 90/10 [F2], and HPMC K15M film [F3]. All films contained propylene glycol (PG-plasticiser). TA solution alone was used as a control. TA permeability via a PermeapadTM barrier, simulating buccal mucosa, was assessed over 8 h using a Franz diffusion cell. TA permeated into the receptor compartment, released in the donor compartment, and located on/within the PermeapadTM barrier were analysed using UV-spectrophotometer. Results 45.7 % drug retention within the PermeapadTM barrier was delivered from F1 (highest). F1, F2, and F3 significantly improved the TA's permeability through PermeapadTM, compared to TA solution alone (e.g., 8.5 % TA-solution, 21.5 %-F1), attributed to the synergy effect of HPMC and propylene glycol acting as penetration enhancers. F1 displayed a significant increase in drug permeability (receptor compartment; 21.5 %) compared to F3 (17.0 %). PVP significantly enhanced drug permeability (27.5 %). Impermeable EC backing layer controlled unidirectional drug release and reduced drug loss into the donor compartment (e.g., ∼28 % for monolayer film to ∼10 % for bilayer film, F1). Significance The mucoadhesive films demonstrated improved TA permeability via PermeapadTM. The findings suggest that these bilayer mucoadhesive films, particularly F1, hold promise for the effective topical treatment of oral mucosa disorders, such as recurrent aphthous stomatitis and oral lichen planus.
materials science, biomaterials,dentistry, oral surgery & medicine